Refine by
Blood Pressure And Ecg Monitors Articles & Analysis
23 news found
Phase 1 studies show improvement in cognitive factors, consistent with therapeutic potential of CY6463 to improve key features in neurological diseases CY6463 favorable tolerability and safety profile was confirmed Ariana Pharma, a leading Artificial Intelligence (AI) drug development company, in collaboration with Cyclerion Therapeutics, presented today safety and pharmacodynamic results ...
Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces a new study in the prestigious Journal of Cardiac Failure demonstrating the importance and clinical utility of Daxor’s BVA-100 blood test in heart failure (HF). The researchers showed that Daxor’s BVA-100 was able to measure intravascular volume overload in heart failure ...
Cingulate Inc. (NASDAQ: CING), a clinical-stage biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products, today announced completion of the formulation study for its third asset, CTx-2103, for the management of anxiety-related disorders. The study was ...
We have just received the completed review on our newest ABPM model from the FDA. ABPM-06 has undergone premarket approval in which procedure its safety and effectiveness has been acknowledged by the U.S. Food & Drug Administration. Even though the accuracy and reliability of our new ABPM has never been questioned, the approval of the FDA (as well as the long-standing CE certificate of the ...
Ariana Pharma, the eXplainable Artificial Intelligence clinical development Company, announced today the presentation of Phase 2 clinical biomarker data from the ANAVEX2-73-PDD-001 Parkinson’s Disease Dementia (PDD) study at the AD/PD 2022 International Conference. MDS-UPDRS Total score improved significantly for patients treated with ANAVEX®2-73 high oral once-daily dose compared to ...
BackBeat CNT treated patients experienced a mean reduction of 17.5 mmHg in office systolic blood pressure measured 24-months following therapy activation. Patients with Isolated Systolic Hypertension (ISH) treated with BackBeat CNT experienced clinically meaningful and statistically significant reductions of 7.4 mmHg in ambulatory systolic blood pressure and 9.4 mmHg in ambulatory Pulse ...
A recent study confirms the high accuracy of the Uscom BP+ central blood pressure monitor for detection of the dangerous cardiac rhythm abnormality Atrial Fibrillation (AF) in a primary care setting. This result confirms that BP+ suprasystolic oscillometry is 94% effective for detection of AF in home care environments and may be used as a screening investigation. ...
Russian regulatory certification for USCOM 1A Cardiac Output Monitor, Russia a significant and growing European market, Uscom continues global expansion. USCOM 1A has received Russian Certification of Registration for sale into the Russian market. The regulatory process is usually 12-18 months but took approximately 3 years following delays with the COVID pandemic. Uscom has worked closely with ...
COPENHAGEN, Denmark--(BUSINESS WIRE)--Neurescue, a medical device company developing innovative cardiovascular solutions to improve the outcomes for emergency patients, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to market the company’s NEURESCUE® device for temporary occlusion of large vessels, including patients requiring emergency ...
Avicenna Cardiology is located on Park Avenue in Manhattan, New York. The clinic is led by Dr. Azadeh Beheshtian, board certified in cardiovascular disease and internal medicine by the American Board of Internal Medicine. Dr. Beheshtian specializes in interventional cardiology and peripheral artery disease, providing top-quality heart care and promoting self-preventive cardiology. Avicenna has ...
Patent protected wireless lung function testing technology, Asthma, COPD, and post-COVID syndrome, Spirometry market is predicted to double in 12 months, Globalisation initiative – Europe, SE Asia and the US. Uscom notifies the market of notice to approve CE mark for the Uscom digital ultrasonic SpiroSonic AIR spirometer. The CE mark is recognition of legal compliance with health, safety ...
At first glance, the news that the federal public health emergency will remain in place through the remainder of 2021 might seem like a bad sign for hopes of quickly beating back COVID-19 and finally returning to normal. But it’s also good news for the continued growth of telehealth, and for patients. Norris Cochran, the acting secretary of the U.S. Department of Health and Human ...
At 11:22 am, April 29, 2021, Baihui dynamic blood pressure ABP-021 was launched into space today along with Tianhe, which will provide blood pressure monitoring services for astronauts for years to come. ...
Late last year, the Federal Communications Commission announced it would award $250 million dollars in funding to nonprofit and public healthcare providers as a part of the COVID-19 Telehealth Program. The COVID-19 Telehealth Program is a reimbursement program that tasks providers with submitting invoice forms and other documentation to receive compensation for telehealth-related expenses. ...
The demand for telehealth in the United States has grown considerably in the past ten years. In 2017, patients were waiting an average of nearly 30 days to see their doctor, whose accessibility is growing increasingly scarce. It’s little wonder that from 2010-2017, the use of telehealth in hospitals increased from 35% to 76%, with nearly every state Medicaid program covering various ...
What is the COVID-19 Telehealth Program? The FCC launched the COVID-19 Telehealth program as a part of the overarching CARES Act in March 2020 to help nonprofit and public health care providers implement connected care services in response to the COVID-19 pandemic. $200 million dollars in funding was distributed to eligible providers who had qualified for the program via the FCC’s ...
HealthTech Arkansas announced the five early-stage companies selected for the 2020 HealthTech Arkansas healthcare accelerator. The accelerator is supported by 11 Arkansas healthcare organizations, including Arkansas Children’s Hospital, Arkansas Heart Hospital, Arkansas Urology, Baptist Health, CHI St. Vincent, Conway Regional Health System, Mercy, OrthoArkansas, St. Bernards Healthcare, ...
RemetricHealth, a leading remote patient monitoring (RPM) and telehealth services company that has been serving the healthcare industry for more than a decade, has announced that its telehealth capabilities, in conjunction with its biometric monitoring devices, are helping connect patients and providers in a time when continuity of care can be challenging due to COVID-19. The telehealth model is ...
ams (SIX: AMS), a leading worldwide supplier of high performance sensor solutions, today announced the release of the first integrated vital sign sensor reference design based on its AS7024.The solution can perform accurate, fast and convenient 24/7 cuffless blood pressure measurement. The new vital signs sensor reference design based on AS7024 integrates all ...
Over 18,000 employers applied, and out of 800 finalists just 100 were named to the final list. Organizations were evaluated on six criteria related to wellness in the workplace: culture and leadership commitment, foundational components of a strong program, strategic planning, communications and marketing, programming and interventions, such as engagement and motivation strategies, and ...